By John Meyer, consultant in financial affairs – Eurasia Business News, June 9, 2025. Article no. 1546.
L’Oréal has agreed to acquire a majority stake in the British skincare brand Medik8, a move that strengthens the French cosmetics giant’s position in the fast-growing dermatological skincare market.
The deal, reportedly valued around €1 billion, involves the UK-based private equity firm Inflexion selling its majority holding while retaining a minority stake, and Medik8’s founder and management team will remain involved to ensure continuity.
Medik8, founded by scientist Elliot Isaacs, is known for its premium, science-backed skincare products, particularly its Crystal Retinal serum and its CSA Philosophy© (Vitamin C and Sunscreen by Day, Vitamin A by night).
The brand emphasizes ingredient-led innovation and delivers high efficacy at an accessible price point, with a diversified omni-channel presence across Europe and growing sales in the US.
This acquisition will integrate Medik8 into L’Oréal’s Luxe Division, complementing its existing skincare portfolio that includes brands like La Roche-Posay, CeraVe, Vichy, and SkinCeuticals. L’Oréal’s dermatological beauty segment is its fastest-growing division, generating over €7 billion in revenue in 2024, driven by consumer demand for scientifically validated skincare products.
L’Oréal plans to consolidate Medik8’s sales following the transaction’s closing, expected within the next few months pending regulatory approvals. The company also secured rights to potentially buy out remaining minority shareholders in the future.
In summary, L’Oréal’s acquisition of a majority stake in Medik8 is a strategic move to bolster its presence in the premium, science-driven skincare market globally, leveraging Medik8’s strong brand and innovation credentials to accelerate growth.
Our community already has nearly 150,000 readers!
Subscribe to our Telegram channel
Follow us on Telegram, Facebook and Twitter
© Copyright 2025 – Eurasia Business News. Article no. 1546.
Eurasia Business News 